In the present study, we show that in animal models bearing tumors, the exogenous administration of GH concomitant with radiation preserves the intestine against acute radiation-induced injury, yet exerts its action without protecting ACC or HCC, while maintaining the antitumor effect of radiotherapy. This evidence concerns the gene GH1 and hepatocellular carcinoma.